Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
This page is not indexed by search engines while we improve data quality.
Mabalirajan Ulaganathan — Human Necessities
Mabalirajan Ulaganathan holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Mabalirajan Ulaganathan |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2016 |
Representative patents
Notable publications linking Mabalirajan Ulaganathan to Human Necessities.
Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
Recent filings
Latest patents from Mabalirajan Ulaganathan in Human Necessities.
Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
US-9302967-B2 · Apr 5, 2016 · US
Related pages
Navigate to parent entity pages.